Dystonias treatment dystonias;Traitement des dystonies

Presse Medicale

Volumn 28, Issue 6, 1999, Pages 312-315

  Marion, M H ^a  

^a Clinique Turin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPA;

BLEPHAROSPASM; DYSTONIA; IDIOPATHIC DISEASE; REVIEW; SPASMODIC TORTICOLLIS;

ADOLESCENT; ADULT; BLEPHAROSPASM; BOTULINUM TOXINS; CHILD; CHILD, PRESCHOOL; CHOLINERGIC ANTAGONISTS; DYSTONIA; FEMALE; HUMANS; MALE;

EID: 0033550772     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Segawa M, Hosaka A., Miyagawa F, Nomura Y, Imai H. Hereditary progressive dystonia with marked diumal fluctuations. Adv Neurol 1976; 14:215-33.
2. Nygaard TG, Trugman JM, De Yebennes JG, Fahn S. Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Neurology 1990; 40:66-9.
3. Marsden CD, Marion M H, Quinn N. The treatment of severe dystonia in children and adults 1984 ; 47:1166-73.
4. Greene P. Baclofen in the treatment of dystonia. Clin Neuropharmacol 1992 ; 15:276-88.
5. Diederich NJ et al. Sustained effect of high dose intrathecal Baclofen in primary generalised dystonia: a 2-year follow-up study. Mov Disord 1997 ; 12:1100-2.
6. Cooper IS. 20-year follow up study of the neurosurgical of dystonia musculorum deformans. In Eldrige R. and Fahn S. (eds) Dystonia, Advances in neurology (New York:Raven Press). 1976 ; vol 14:423-47
7. Lozano AM et al. Globus pallidus internus pallidotomy for generalised dystonia. Mov Disord 1997 ; 12:865-70.
8. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophtalmology 1980 ; 87:1044-9.
9. Simpson LL. The origin, structure and pharmacological activity of botulism toxin. Pharmacol Rev 1981 ; 33:155-88.
10. Melling J, Hambleton P, Shone CC. Clostridium botulinum toxins : nature and preparation for clinical use. Eye 1988 ; 2:16-23.
11. Duchen LW. An electron microscope study of the changes induced by botulinum toxin in the motor and plates of slow and fast skeletal muscles fibres of the mouse. J Neurol Sci 1971 ; 14:47-60.
12. DeCamilli P. Exocytosis goes with a SNAP. Nature 1993 ; 364:387-8.
13. Marion MH, Sheehy M, Sangla S et al. Dose standardisation of botulinum toxin. J Neurol Neurosurg Psychiatry 1995 ; 59:102-3.
14. Lange DJ, Brin MF, Sahn S et al. Distant effects of locally injected botulinum toxin : incidence and course. Advances in Neurology, vol 50:Dystonia 2. Raven press, 1988 ; 609-13.
15. Ansved T, Odergren T, Borg K. Muscle fiber atrophy in leg muscles after Botulinum toxin type A treatment of cervical dystonia. Neurology 1997 ; 48:1440-66.
16. Houser M K, Shean GL, Lees AJ. Further studies using higher doses of botulinum toxin type F for torticolis resistant to botulinum toxin type A. J Neurol Neurosurg Psychiatry 1988 ; 64:577-80.
17. Lew MF et al. Botulinum toxin type B : a double blind placebo-controlled, safety and efficacy study in cervical dystonia. Neurology 1997 ; 49:701-7.
18. Elston JS, Ross Russel RW. Effect of treatment with botulinum toxin on neurogenic blepharospasm. BMJ 1985 ; 290:1857-9.
19. Elston JS. The management of blepharospasm and hemifacial spasm. J Neurol 1992 ; 239:5-8.
20. Krack P, Marion MH. "Aprexia of lid opening", a focal dystonia : clinical study of 32 patients. Movement Disorders 1994 ; 9:610-15.
21. Tsui JK, Eisen A, Stoessl AJ et al. Double blind study of botulinum toxin in spasmodic torticollis. Lancet 1986 ; ii:245-7.
22. Blackie JD, Lees AJ. Botulinum toxin treatment in spasmodic torticollis. J Neurol Neurosurg Psychiatry 1990 ; 53:640-3.
23. Bleton JP. Rééducation des dystonies localisées. Encyclop Chir (Paris), Kinésithéraple. 1989:26452,B10,4.
24. Krauss et al. Symptomatic and functionnal outcome of surgical treatment of cervical dystonia. J Neurol Neurosurg Psychiatry 1997 ; 63:642-8.
25. Bertrand CM. Selectve peripheral denervation for spasmodic torticollis: surgical technique, results, and observations in 260 cases. Surg Neurol 1993 ; 25:153-8.
26. Blitzer A, Brin MF et al. Botulinum toxin injection for the treatment of oromandibular dystonia. Ann Otol Rhinol Laryngol 1989 ; 98:93-7.
27. Cohen LG, Hallet M, Geller BD et al. Treatment of focal dystonias of hand with botulinum toxin injections. J Neurol Neurosurg Psychiatry 1989 ; 52:355-63.
28. Miller RH, Woodson GE, Jankovic J. Botulinum toxin injection of the vocal fold for spasmodic dysphonia : a preliminary report. Arch Otolaryngol Head Neck Surg 1987 ; 113:603-5.
29. Klap P, Marion MH, Perrin A et al. Traitement de la dysphonie spasmodique par la toxine botulique. Ann Otolaryngol 1991 ; 108:477-83.
30. Marion MH, Klap P, Perrin A et al. Stridor and focal laryngeal dystonia. Lancet 1992 ; 339:457-8.
31. Bhatia KP, Quinn NP, Marsden CD. Clinical features and natural history of axial predominant adult onset primary dystonia. J Neurol Neurosurg and Psychiatry 1997 ; 63:788-91.